Practice
Featured experience
ExxonMobil $59.5 billion acquisition of Pioneer Natural Resources
We are advising ExxonMobil on the transaction
PSG VI $6 billion fundraise and $2 billion continuation fund
We advised PSG on the fundraise for PSG VI and a multi-asset GP-led secondary continuation fund transaction
Circle $1.05 billion IPO
We are advising Circle on its IPO, the first IPO by a stablecoin issuer
Switch data center project financing transactions
We advised the lenders on the project financings
Maze Therapeutics $150 million private placement
The PIPE included common stock and pre-funded warrants
Alnylam Pharmaceuticals $661.25 million convertible senior notes offering
The 0% convertible notes are due 2028
Alnylam Pharmaceuticals $661.25 million convertible senior notes offering
The 0% convertible notes are due 2028
Alnylam Pharmaceuticals $661.25 million convertible senior notes offering
The 0% convertible notes are due 2028
Legence $728 million IPO
The shares are listed on the Nasdaq Global Select Market
Legence $728 million IPO
The shares are listed on the Nasdaq Global Select Market
Legence $728 million IPO
The shares are listed on the Nasdaq Global Select Market
Crane NXT €445 million acquisition of Antares Vision
We are advising Crane NXT on the transaction
Crane NXT €445 million acquisition of Antares Vision
We are advising Crane NXT on the transaction
Crane NXT €445 million acquisition of Antares Vision
We are advising Crane NXT on the transaction